PRDM5 and neoplasm: Our finding that ectopic expression of PRDM5 leads to the inhibition of WNT/β-catenin signaling in tumor cells, probably through upregulating DKK1, DKK2, and WNT5A[18], suggests a novel mechanistic link between PRDM5 and WNT signaling in human tumorigenesis.